Hirotaka Hasegawa Selected Research

Hirotaka Hasegawa Research Topics

16	Neoplasms (Cancer) 07/2023 - 04/2012
3	Meningioma (Meningiomas) 06/2023 - 01/2018
3	Arteriovenous Malformations (Arteriovenous Malformation) 11/2022 - 03/2020
3	Chondrosarcoma 02/2022 - 01/2018
2	Hemorrhage 08/2023 - 08/2017
2	Aneurysm (Aneurysms) 10/2016 - 01/2014
2	Embolism (Embolus) 04/2015 - 09/2014
2	Rupture 04/2015 - 09/2014
1	Neurilemmoma (Schwannoma) 12/2023
1	Chordoma 07/2023
1	Craniopharyngioma (Craniopharyngiomas) 07/2023
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2023
1	Mycoses (Diseases, Fungus) 01/2023
1	Sinusitis 01/2023
1	Postoperative Hemorrhage 11/2022
1	Wounds and Injuries (Trauma) 09/2022
1	Surgical Wound Infection 09/2022
1	Meningitis 09/2022
1	Adenocarcinoma 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Eagle syndrome 01/2022
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2022
1	Trigeminal Neuralgia (Tic Douloureux) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Weight Gain 12/2020
1	Weight Loss (Weight Reduction) 12/2020
1	Deglutition Disorders (Dysphagia) 12/2020
1	Cicatrix (Scar) 12/2020
1	Solitary Fibrous Tumors 08/2018
1	Necrosis 08/2017
1	Inflammation (Inflammations) 08/2017
1	Thrombosis (Thrombus) 10/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2014
1	Carotid-Cavernous Sinus Fistula 01/2014
1	Anorexia 04/2012
1	Fatigue 04/2012
1	Abdominal Pain (Pain, Abdominal) 04/2012
1	Breast Neoplasms (Breast Cancer) 04/2012
1	Diarrhea 04/2012
1	Nausea 04/2012

3	Dihydrotachysterol (AT 10)IBA 12/2023 - 12/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 12/2020
1	Indicators and Reagents (Reagents)IBA 06/2023
1	Antifungal AgentsIBA 01/2023
1	EnbucrilateIBA 11/2022
1	Bone SubstitutesIBA 01/2022
1	NivolumabIBA 01/2022
1	N-succinimidyl 8-((4'-fluorobenzyl)amino)suberateIBA 01/2022
1	Retinaldehyde (Retinal)IBA 07/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021
1	ivalon spongeIBA 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	SaltsIBA 12/2020
1	Vasopressins (Vasopressin)IBA 12/2020
1	GadoliniumIBA 08/2017
1	N(6)-allyl-N(6)-cyclohexyladenosineIBA 10/2016
1	neratinibIBA 04/2012
1	Epidermal Growth Factor (EGF)IBA 04/2012

9	Radiotherapy 07/2023 - 01/2018
4	Therapeutics 04/2023 - 01/2018
3	Craniotomy 09/2022 - 04/2015
3	Carotid Endarterectomy 01/2022 - 09/2014
2	Endoscopes 01/2022 - 01/2017
2	Embolectomy 04/2015 - 09/2014
1	Aftercare (After-Treatment) 08/2023
1	Debridement 09/2022
1	Neoadjuvant Therapy 01/2022
1	Free Tissue Flaps 01/2022
1	Gastrectomy 01/2022
1	Surgical Decompression 07/2021
1	Ovariectomy (Oophorectomy) 01/2021
1	Microvascular Decompression Surgery 01/2021
1	Hemodilution 12/2020
1	Electrodes (Electrode) 12/2020
1	Catheters 12/2020
1	Drug Tapering 12/2020
1	Adjuvant Radiotherapy 08/2018
1	Ligation 01/2014